Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERIAL Trial
NCT04770012Phase 3Recruiting
- Sponsor
- University of Ottawa Heart Institute
- Start
- Jun 2021
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, clopidogrel in cardiac allograft vasculopathy (CAV), sponsored by University of Ottawa Heart Institute. Started Jun 2021; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
cardiac allograft vasculopathy (CAV)
Beyond the preview
Go deeper on NCT04770012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04770012.